Amaury Dumont
About Amaury Dumont
Amaury Dumont serves as the Associate Medical Director for Cell Therapy at Gilead Sciences, where he has worked since 2018. He has extensive experience in oncology and hematology, contributing to the development of innovative cancer treatments.
Current Role at Gilead Sciences
Amaury Dumont serves as the Associate Medical Director for Cell Therapy at Gilead Sciences, a position he has held since 2018. Located in Foster City, California, he has contributed significantly to the development of innovative treatments in oncology and hematology. His focus includes improving survival rates for cancer patients through advanced therapeutic strategies.
Education and Expertise
Amaury Dumont has an extensive educational background. He earned his Doctorate in Philosophy from The University of Texas Health Science Center at Houston, where he studied Biology and Philosophy from 2008 to 2012. Additionally, he holds a Doctorate in Pharmacy from Paris - Sud University, completed between 1998 and 2005. His expertise includes developing innovative target therapies, epigenetic approaches, Immuno-Oncology, and CAR T-cell therapies.
Professional Background
Amaury Dumont has held various positions in the pharmaceutical and research sectors. Prior to his current role, he worked at Bristol-Myers Squibb as a Medical Science Manager in Immuno-oncology and as a Disease Area Specialist focusing on lung cancer and melanoma. His experience also includes roles at Institut Curie, University of Miami, and MD Anderson Cancer Center, where he contributed to oncology research and project management.
Achievements in Oncology
Amaury Dumont is recognized for his contributions to oncology and hematology, particularly in the development of treatments aimed at improving cancer patient survival. His strategic medical and scientific leadership in CAR-T and TCR programs in France has focused on new therapeutic areas, including lymphoma, leukemia, myeloma, and solid tumors.
Mentorship and Leadership
Amaury Dumont is known for his positive attitude and is recognized as a mentor in the field of oncology. His strong analytical skills, creative problem-solving abilities, and excellent communication skills have contributed to his effectiveness in providing leadership and guidance in various medical and scientific initiatives.